Sarasin & Partners LLP Merck & Co., Inc. Transaction History
Sarasin & Partners LLP
- $10.6 Billion
- Q3 2024
A detailed history of Sarasin & Partners LLP transactions in Merck & Co., Inc. stock. As of the latest transaction made, Sarasin & Partners LLP holds 1,884,285 shares of MRK stock, worth $201 Million. This represents 2.02% of its overall portfolio holdings.
Number of Shares
1,884,285
Previous 2,268,362
16.93%
Holding current value
$201 Million
Previous $281 Million
23.8%
% of portfolio
2.02%
Previous 2.49%
Shares
24 transactions
Others Institutions Holding MRK
# of Institutions
3,811Shares Held
1.92BCall Options Held
13.4MPut Options Held
10.7M-
Vanguard Group Inc Valley Forge, PA245MShares$26.1 Billion0.59% of portfolio
-
Black Rock Inc. New York, NY207MShares$22.1 Billion0.59% of portfolio
-
State Street Corp Boston, MA117MShares$12.5 Billion0.65% of portfolio
-
Wellington Management Group LLP Boston, MA72.5MShares$7.73 Billion1.64% of portfolio
-
Geode Capital Management, LLC Boston, MA57MShares$6.08 Billion0.63% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $270B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...